Literature DB >> 12891382

Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma.

E I Hauben1, J Arends, J P Vandenbroucke, C J van Asperen, E Van Marck, P C W Hogendoorn.   

Abstract

The overall incidence of osteosarcoma is low. However, the occurrence of osteosarcoma in a setting of multiple primary tumours is not infrequent, although population-based incidence numbers are unknown. The occurrence of osteosarcoma and other malignancies is frequently related to treatment, and can also be the result of genetic predisposition as in patients with retinoblastoma, Li-Fraumeni syndrome, Werner syndrome and Rothmund-Thomson syndrome. The aim of our study is to establish the incidence of osteosarcoma associated with other malignancies in a populationwide study and to find out if these osteosarcomas have a specific subtype, that could draw attention to a genetic predisposition to malignancy. A list of all patients registered in the Dutch National Pathology Register, named PALGA, with a diagnosis of osteosarcoma between 1975 and May 2000 was retrieved. All patients with another malignancy besides osteosarcoma were selected. All patients registered in the same period with a tonsillectomy served as a control for the occurrence of malignancy in a normal population. In a second step, only osteosarcoma patients with a history of retinoblastoma or a malignancy before the age of 46 years, since these are most probable to have a hereditary cancer syndrome, were retained for further analysis. The osteosarcomas were subtyped as common, chondroblastic, fibroblastic, teleangiectatic, anaplastic, osteoclast-rich or small cell. As a control for osteosarcoma subtypes the data of 570 patients entered in two studies from the European Osteosarcoma Intergroup (EORTC/MRC) were used. Of all 938 patients registered with the diagnosis of osteosarcoma, 66 had a history of multiple primary tumours. Four patients had a surface osteosarcoma, three an extraskeletal osteosarcoma and 59 had intramedullar high-grade osteosarcoma. Of this last group, one patient was known with Rothmund-Thomson syndrome, one had retinoblastoma and 30 had their malignancies before the age of 46. Of these 32 patients, 17 had osteosarcoma of the long bones. Especially women seem to be more susceptible for the development of multiple primaries. In nine patients, the histological subtype could be assessed by revision of available histological slides. All of these patients had an osteosarcoma subtype other than common as opposed to 29% in the control group of the European Osteosarcoma Intergroup. It is concluded that although the incidence of osteosarcoma is low, the occurrence of another malignancy in osteosarcoma patients is higher than in the normal population. Specifically, osteosarcoma patients have a relative risk of 2.4 (95% confidence interval 1.88-3.07) to develop another malignancy. A noncommon subtype of osteosarcoma should draw attention to a possible genetic predisposition of the patient involved.

Entities:  

Mesh:

Year:  2003        PMID: 12891382     DOI: 10.1038/sj.ejhg.5201012

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  29 in total

1.  Twenty years of follow-up of survivors of childhood osteosarcoma: a report from the Childhood Cancer Survivor Study.

Authors:  Rajaram Nagarajan; Anmmd Kamruzzaman; Kirsten K Ness; Victoria G Marchese; Charles Sklar; Ann Mertens; Yutaka Yasui; Leslie L Robison; Neyssa Marina
Journal:  Cancer       Date:  2010-10-04       Impact factor: 6.860

2.  Associations of polymorphisms in the bone morphogenetic protein-2 gene with risk and prognosis of osteosarcoma in a Chinese population.

Authors:  Yu Cong; Cheng-Jun Li; Jian-Ning Zhao; Xiao-Zhou Liu; Xin Shi
Journal:  Tumour Biol       Date:  2014-11-13

Review 3.  Pathology of primary malignant bone and cartilage tumours.

Authors:  L B Rozeman; A M Cleton-Jansen; P C W Hogendoorn
Journal:  Int Orthop       Date:  2006-08-30       Impact factor: 3.075

4.  Microarray analysis identifies distinct gene expression profiles associated with histological subtype in human osteosarcoma.

Authors:  Bernd Kubista; Florian Klinglmueller; Martin Bilban; Martin Pfeiffer; Richard Lass; Alexander Giurea; Phillipp T Funovics; Cyril Toma; Martin Dominkus; Rainer Kotz; Theresia Thalhammer; Klemens Trieb; Teresa Zettl; Christian F Singer
Journal:  Int Orthop       Date:  2010-03-26       Impact factor: 3.075

Review 5.  Surgical treatment of sarcomas of the spine.

Authors:  Ali K Ozturk; Ziya L Gokaslan; Jean-Paul Wolinsky
Journal:  Curr Treat Options Oncol       Date:  2014-09

6.  [Hereditary bone tumors].

Authors:  D Baumhoer
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

7.  Low miR-34a and miR-192 are associated with unfavorable prognosis in patients suffering from osteosarcoma.

Authors:  Yuan Wang; Lian-Shun Jia; Wen Yuan; Zhao Wu; Hai-Bo Wang; Tao Xu; Jing-Chuan Sun; Ke-Fu Cheng; Jian-Gang Shi
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

8.  Osteosarcoma and second malignant neoplasms: a case series.

Authors:  R L Geary; L R Corrigan; D N Carney; M J Higgins
Journal:  Ir J Med Sci       Date:  2019-05-03       Impact factor: 1.568

9.  Secondary supratentorial primitive neuroectodermal tumor following treatment of childhood osteosarcoma.

Authors:  Courtney D Fitzhugh; Barbara Wise; Kristin Baird; Maria Tsokos; Lee Helman; Crystal Mackall; Sharon A Savage; Katherine E Warren
Journal:  Pediatr Blood Cancer       Date:  2009-09       Impact factor: 3.167

10.  Risedronate inhibits human osteosarcoma cell invasion.

Authors:  Zeng Feng Xin; Yang Kyung Kim; Sung Taek Jung
Journal:  J Exp Clin Cancer Res       Date:  2009-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.